Clinical Trials Logo

Safety clinical trials

View clinical trials related to Safety.

Filter by:

NCT ID: NCT05073744 Recruiting - Safety Clinical Trials

Nalbuphine Versus Morphine for Perioperative Tumor Ablation

Start date: September 5, 2021
Phase: Phase 4
Study type: Interventional

This randomized, positive control, multicentre trial is designed to compare the analgesic efficacy and safety of nalbuphine hydrochloride injection and morphine hydrochloride injection for perioperative tumor ablation.

NCT ID: NCT04785729 Recruiting - Safety Clinical Trials

Almonertinib Combined With Pyrotinib in the Treatment of Advanced NSCLC Patients With HER-2 Amplification/Mutation After EGFR-TKI Resistance

APPEAR
Start date: December 31, 2020
Phase: Phase 2
Study type: Interventional

This is a multicenter, open, phase II clinical trial to evaluate the safety and efficacy of almonertinib combined with pyrrolitinib in locally advanced or metastatic NSCLC patients with her-2 variants detected after first-line EGFR-TKI treatment resistance. Patients with first-line EGFR-TKI resistance showed HER-2 variation (including mutation and amplification) in tissue or blood tests, and the treatment regimen of metinil combined with pyrrolitinib was performed to evaluate the safety and efficacy of the treatment regimen. To determine the optimal dose of pyrrolitinib, three dose groups of 240mg, 320mg, and 400mg were set, and the "3+3" study design principle was adopted. About 27-36 people will be included in the study (depending on the progress of the study)

NCT ID: NCT04758845 Recruiting - Safety Clinical Trials

Clinical Study to Evaluate the Safety and Efficacy of New Probiotic Strains in Health Adults

Start date: February 11, 2021
Phase: N/A
Study type: Interventional

This trial is to determine the safety of 4 new probiotic strains and to assess their efficacy in reducing the incidence and/or duration of gastrointestinal problems and infections as well as respiratory infections in healthy adults.

NCT ID: NCT04626583 Recruiting - Safety Clinical Trials

Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells

Start date: March 5, 2021
Phase: Phase 1
Study type: Interventional

This study is a longitudinal assessment using a classic dose-escalation study design to assess the safety and maximal tolerated dose (MTD) of locally delivered allogeneic mesenchymal stromal cells (MSC) for promoting corneal repair. The study will be conducted at Illinois Eye and Ear Infirmary located at University of Illinois at Chicago. The study will use digital conjunctival and corneal photography and corneal Scheimpflug Imaging, densitometry, and pachymetry for assessment of safety and corneal wound healing.

NCT ID: NCT04069780 Recruiting - Safety Clinical Trials

Suprachoroidal Injection of Triamcinolone Acetonide for Management of Diabetic Macular Edema

SCI
Start date: March 13, 2019
Phase: N/A
Study type: Interventional

Intravitreal triamcinolone acetonide is a well-known method of treatment of diabetic macular edema, however, it has many side effects, most commonly causing cataract and glaucoma. Suprachoroidal route is an emerging route of delivery of intraocular drugs. This is to our knowledge the first prospective study to compare the effect of triamcinolone acetonide delivered via the intravitreal versus the suprachoroidal route in the treatment of diabetic macular edema as regards safety and efficacy.

NCT ID: NCT04013646 Recruiting - Stroke Clinical Trials

Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients

Start date: May 2, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

This clinical trial is a clinical trial for the evaluation of the safety and efficacy of umbilical cord blood (UCB) therapy, UCB and erythropoietin (EPO) combination therapy in adult stroke patients.

NCT ID: NCT03927235 Recruiting - Safety Clinical Trials

The Diagnostic Yield and Safety of Transbronchial Cryobiopsy in Different Freezing Time in the Diffuse Parenchymal Lung Diseases

Start date: May 16, 2019
Phase: N/A
Study type: Interventional

Transbronchial cryobiopsy in different freezing time is performed in patients with undefined diffuse parenchymal lung diseases, and assess the diagnostic yield and safety.

NCT ID: NCT03908138 Recruiting - Multiple Myeloma Clinical Trials

RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma

Start date: March 30, 2019
Phase: Phase 4
Study type: Interventional

Multiple myeloma (MM) is a common malignant hematology disease. The development of proteasome inhibitors (PIs) and immunomodulatory drugs (IMiDs) significantly improved the survival of MM patients. IMiDs have multiple effects in MM therapy. Except for direct cytotoxicity, IMiDs also play a variety of immune regulatory roles. Lenalidomide, a kind of IMiDs, was usually used in the therapy of relapsed/refractory MM. The efficacy and safety of RDD (lenalidomide, pegylated liposomal doxorubicin, dexamethasone) in newly diagnosed patients with MM still needs to be further validated.

NCT ID: NCT03715114 Recruiting - Pharmacokinetics Clinical Trials

A Study to Assess the Safety and Pharmacokinetics of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Subjects

Start date: October 15, 2018
Phase: Phase 1
Study type: Interventional

To evaluate the safety and pharmacokinetics of GV-971 capsules after oral a single or multiple doses of 900 mg, 1200 mg and 1500 mg in healthy subjects.

NCT ID: NCT03512379 Recruiting - Safety Clinical Trials

Clinical Trial for the Application of Robotic System in Spinal Surgery

Start date: August 1, 2015
Phase: N/A
Study type: Interventional

This randomized controlled study was designed to evaluate the accuracy, safety and clinical outcomes of the robot assisted spinal surgery.